Provided by Tiger Trade Technology Pte. Ltd.

Therapeutics

5.11
+0.30006.24%
Post-market: 4.72-0.3878-7.59%19:30 EDT
Volume:680.21K
Turnover:3.33M
Market Cap:159.89M
PE:-1.24
High:5.13
Open:4.80
Low:4.69
Close:4.81
52wk High:50.40
52wk Low:4.54
Shares:31.29M
Float Shares:18.39M
Volume Ratio:1.36
T/O Rate:3.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1300
EPS(LYR):-2.8503
ROE:-59.21%
ROA:-37.36%
PB:0.73
PE(LYR):-1.79

Loading ...

Alterity Therapeutics Doubles Annual Loss as It Ramps Up Neurodegeneration R&D

TIPRANKS
·
Aug 28

Amplia Therapeutics Highlights Strong Pancreatic Cancer Data in AGM CEO Presentation

TIPRANKS
·
Aug 28

Kazia Therapeutics Posts 100% Clinical Benefit in Early Triple-Negative Breast Cancer Paxalisib Study

TIPRANKS
·
Aug 28

Quince Therapeutics Announces Planned Presidential Leadership Transition

TIPRANKS
·
Aug 28

Rein Therapeutics Receives Nasdaq Delisting Notice Over Bid Price

TIPRANKS
·
Aug 28

ADRs Close Higher; Kazia Therapeutics Ltd. Climbs 16%

Dow Jones
·
Aug 28

Kazia Therapeutics reports 100% clinical benefit rate in breast cancer treatment

TIPRANKS
·
Aug 28

Kazia Therapeutics announces offering of ADS, warrants

TIPRANKS
·
Aug 28

Outlook Therapeutics Appoints Kevin Lundquist as Chief Financial Officer as It Prepares for U.S. Commercial Launch of LYTENAVA™

GlobeNewswire
·
Aug 28

Akari Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference

GlobeNewswire
·
Aug 27

Serina Therapeutics Establishes Flexible Equity Financing Agreement

TIPRANKS
·
Aug 27

JW Therapeutics Narrows Interim Loss as Carteyva Sales Jump and Costs Ease

TIPRANKS
·
Aug 27

The Consensus EPS Estimates For GenFleet Therapeutics (Shanghai) Inc. (HKG:2595) Just Fell Dramatically

Simply Wall St.
·
Aug 27

Rapid Dose Therapeutics Secures Second Patent for QuickStrip Nicotine Oral Film

TIPRANKS
·
Aug 27

Is Elanco (ELAN) Quietly Reframing Its Pet Therapeutics Strategy With This Kansas Antibody Expansion?

Simply Wall St.
·
Aug 27

Spyre Therapeutics falls -13.2%

TIPRANKS
·
Aug 27

Spyre Therapeutics Down over 12%, on Pace for Largest Percent Decrease Since June 2024

Dow Jones
·
Aug 26

Summit Therapeutics’ Ivonescimab Shows Phase III Survival Benefit

TIPRANKS
·
Aug 26

Tyler Van Buren Reiterates Buy on Oruka Therapeutics Citing Superior PASI 100 Data, Upcoming Durability Readouts, and Accelerated Pipeline Timelines

TIPRANKS
·
Aug 26

Mineralys Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference

GlobeNewswire
·
Aug 26